Published Patent: Lipocalin-2 As A Prognostic And Diagnostic Marker For Heart And Stroke Risks

File Download
Patent History
  • Application
    US 12/113056
    2008-04-30
  • Publication
    US 20090274709
    2009-11-05
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleLipocalin-2 As A Prognostic And Diagnostic Marker For Heart And Stroke Risks
Priority Date2008-04-30 US 12/113056
InventorsXu, Aimin
Wang, Yu
Xu, Aimin
Cautherley, George William Hunter
Chan, Cangel Pui Yee
Lehmann, Matthias
CitationUS Published patent application 20090274709. Washington, DC: US Patent and Trademark Office (USPTO), 2009 [How to Cite?]
AbstractMethods And Apparatus Are Disclosed For The Measurement Of Lipocalin-2 In Body Fluids (Including But Not Limited To Blood, Serum, Plasma, Urine, Saliva, Tear, Etc.) By An Assay Such As An Immunoassay Or An Immunotest For (1) The Prediction Of Risk Of Future Cardiovascular Diseases; And (2) The Determination Of The Likelihood That Certain Individuals Will Benefit To A Greater Or Lesser Extent From The Use Of Certain Treatments Designed To Prevent And/Or Treat Cardiovascular Diseases.
DC Field
Value
dc.contributor.inventorXu, Aimin
dc.contributor.inventorWang, Yu
dc.contributor.inventorXu, Aimin
dc.contributor.inventorCautherley, George William Hunter
dc.contributor.inventorChan, Cangel Pui Yee
dc.contributor.inventorLehmann, Matthias
dc.date.accessioned2011-10-19T06:35:24Z
patents.date.application2008-04-30
dc.date.available2011-10-19T06:35:24Z
patents.date.priority2008-04-30 US 12/113056
patents.date.publication2009-11-05
dc.description.abstractMethods And Apparatus Are Disclosed For The Measurement Of Lipocalin-2 In Body Fluids (Including But Not Limited To Blood, Serum, Plasma, Urine, Saliva, Tear, Etc.) By An Assay Such As An Immunoassay Or An Immunotest For (1) The Prediction Of Risk Of Future Cardiovascular Diseases; And (2) The Determination Of The Likelihood That Certain Individuals Will Benefit To A Greater Or Lesser Extent From The Use Of Certain Treatments Designed To Prevent And/Or Treat Cardiovascular Diseases.
patents.description.assigneeVersitech Limited And R & C Biogenius Limited
patents.description.ccUS
patents.description.countryUnited States of America
patents.description.kindA1
dc.description.naturelink_to_OA_fulltext
patents.identifier.applicationUS 12/113056
dc.identifier.citationUS Published patent application 20090274709. Washington, DC: US Patent and Trademark Office (USPTO), 2009 [How to Cite?]
patents.identifier.hkutechidMedi-2008-00273
patents.identifier.publicationUS 20090274709
dc.identifier.urihttp://hdl.handle.net/10722/142218
patents.relation.familyCN 102026655 (A) 2011-04-20
patents.relation.familyEP 2300048 (A1) 2011-03-30
patents.relation.familyJP 2011519037 (A) 2011-06-30
patents.relation.familyUS 2009274709 (A1) 2009-11-05
patents.relation.familyUS 8030097 (B2) 2011-10-04
patents.relation.familyWO 2009132510 (A1) 2009-11-05
dc.relation.isreferencedbyWO 2011100426 (A2) 2011-08-18
dc.relation.isreferencedbyWO 2011100426 (A3) 2011-12-22
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents
dc.titleLipocalin-2 As A Prognostic And Diagnostic Marker For Heart And Stroke Risks
dc.typePatent
patents.typePatent_published